Correction to "Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy"

Dinh Chuong Nguyen,Kefan Song,Simbarashe Jokonya,Omeed Yazdani,Drew L Sellers,Yonghui Wang,Abm Zakaria,Suzie H Pun,Patrick S Stayton

DOI: https://doi.org/10.1021/acscentsci.4c00532

2024-04-16

Abstract:[This corrects the article DOI: 10.1021/acscentsci.3c01310.].

What problem does this paper attempt to address?

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Xi Jiang,Chao Hu,Kyle Ferchen,Ji Nie,Xiaolong Cui,Chih-Hong Chen,Liting Cheng,Zhixiang Zuo,William Seibel,Chunjiang He,Yixuan Tang,Jennifer R. Skibbe,Mark Wunderlich,William C. Reinhold,Lei Dong,Chao Shen,Stephen Arnovitz,Bryan Ulrich,Jiuwei Lu,Hengyou Weng,Rui Su,Huilin Huang,Yungui Wang,Chenying Li,Xi Qin,James C. Mulloy,Yi Zheng,Jiajie Diao,Jie Jin,Chong Li,Paul P. Liu,Chuan He,Yuan Chen,Jianjun Chen

DOI: https://doi.org/10.1038/s41467-018-02947-0

IF: 16.6

2018-01-01

Nature Communications

Abstract:The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Haotian Shen,Lulu Jin,Qiangqiang Zheng,Ziqiang Ye,Linxiang Cheng,Yuxu Wu,Honghao Wu,Tae Gyong Jon,Wenduo Liu,Zongyou Pan,Zhengwei Mao,Yue Wang

DOI: https://doi.org/10.1016/j.bioactmat.2024.08.007

2024-08-22

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.12.001.].
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Kin Man Au,Rod Balhorn,Monique C Balhorn,Steven I Park,Andrew Z Wang

DOI: https://doi.org/10.1021/acscentsci.4c00703

2024-05-08

Abstract:[This corrects the article DOI: 10.1021/acscentsci.8b00746.].
Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Alasdair G. Kay,James M. Fox,James P. Hewitson,Andrew P. Stone,Sophie Robertson,Sally James,Xiao-nong Wang,Elizabeth Kapasa,Xuebin B. Yang,Paul G. Genever

DOI: https://doi.org/10.3389/fimmu.2022.1111042

IF: 7.3

2022-12-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.903796.].

immunology
Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Ju Huang,Fengqiu Liu,Xiaoxia Han,Liang Zhang,Zhongqian Hu,Qinqin Jiang,Zhigang Wang,Haitao Ran,Dong Wang,Pan Li

DOI: https://doi.org/10.7150/thno.67168

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.29569.].

medicine, research & experimental
Author Correction: STEEP mediates STING ER exit and activation of signaling

Bao-cun Zhang,Ramya Nandakumar,Line S. Reinert,Jinrong Huang,Anders Laustsen,Zong-liang Gao,Cheng-long Sun,Søren Beck Jensen,Anne Troldborg,Sonia Assil,Martin F. Berthelsen,Carsten Scavenius,Yan Zhang,Samuel J. Windross,David Olagnier,Thaneas Prabakaran,Chiranjeevi Bodda,Ryo Narita,Yujia Cai,Cong-gang Zhang,Harald Stenmark,Christine M. Doucet,Takeshi Noda,Zheng Guo,Raphaela Goldbach-Mansky,Rune Hartmann,Zhijian J. Chen,Jan J. Enghild,Rasmus O. Bak,Martin K. Thomsen,Søren R. Paludan

DOI: https://doi.org/10.1038/s41590-020-0803-5

IF: 30.5

2020-09-14

Nature Immunology

Abstract:An amendment to this paper has been published and can be accessed via a link at the top of the paper.

immunology
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Author Correction: Anti-tumour Immunity Controlled Through Mrna M 6 A Methylation and YTHDF1 in Dendritic Cells

Dali Han,Jun Liu,Chuanyuan Chen,Lihui Dong,Yi Liu,Renbao Chang,Xiaona Huang,Yuanyuan Liu,Jianying Wang,Urszula Dougherty,Marc B. Bissonnette,Bin Shen,Ralph R. Weichselbaum,Meng Michelle Xu,Chuan He

DOI: https://doi.org/10.1038/s41586-019-1046-1

IF: 64.8

2019-01-01

Nature

Abstract:In this Letter, a citation to ‘Fig. 1e’ has been corrected to ‘Fig. 1d’ in the sentence starting “By contrast, the anti-tumour response…”. This has been corrected online
Correction: Synthesis and Immunological Evaluation of MUC1 Glycopeptide Conjugates Bearing N-acetyl Modified STn Derivatives As Anticancer Vaccines.

An Xiao,Xiu‐Jing Zheng,Chengcheng Song,Yue Gui,Chang‐Xin Huo,Xin‐Shan Ye

DOI: https://doi.org/10.1039/c7ob90028g

2017-01-01

Organic & Biomolecular Chemistry

Abstract:Correction for 'Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines' by An Xiao et al., Org. Biomol. Chem., 2016, 14, 7226-7237.
Author Correction to ‘mevalonate Improves Anti-Pd-1/pd-l1 Efficacy by Stabilizing CD274 Mrna’ [acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Wenxin Zhang,Xiaohui Pan,Yanjun Xu,Hongjie Guo,Mingming Zheng,Xi Chen,Honghai Wu,Fengming Luan,Qiaojun He,Ling Ding,Bo Yang

DOI: https://doi.org/10.1016/j.apsb.2023.07.023

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2023.04.002.].
Correction To: Targeted Therapy for Cisplatin‐resistant Lung Cancer Via Aptamer‐guided Nano‐zinc Carriers Containing USP14 Sirna

Xinmin Zhao,Xianghua Wu,Huijie Wang,Songtao Lai,Jialei Wang

DOI: https://doi.org/10.1002/mco2.237

2023-01-01

MedComm

Abstract:[This corrects the article DOI: 10.1002/mco2.237.].
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Zhuolong Zhou,Kevin Van der Jeught,Yuanzhang Fang,Tao Yu,Yujing Li,Zheng Ao,Sheng Liu,Lu Zhang,Yang Yang,Haniyeh Eyvani,Mary L. Cox,Xiyu Wang,Xiaoming He,Guang Ji,Bryan P. Schneider,Feng Guo,Jun Wan,Xinna Zhang,Xiongbin Lu

DOI: https://doi.org/10.1038/s41551-023-01096-0

IF: 28.1

2023-08-31

Nature Biomedical Engineering

Abstract:Nature Biomedical Engineering, Published online: 30 August 2023; doi:10.1038/s41551-023-01096-0 Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

engineering, biomedical
Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection”

Soledad Stagnoli,Gabriele Macari,Pietro Corsi,Barbara Capone,Ander Vidaurrazaga,June Ereño-Orbea,Ana Ardá,Fabio Polticelli,Jesus Jimenez-Barbero,Nicola Ga Abrescia,Ivan Coluzza,Nicola GA Abrescia

DOI: https://doi.org/10.1021/acsomega.3c10152

IF: 4.1

2024-01-18

ACS Omega

Abstract:[This corrects the article DOI: 10.1021/acsomega.3c02921.].

chemistry, multidisciplinary
Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Zhilin Li,Hao Cai,Zhiqian Li,Long Ren,Xuelei Ma,Hongyan Zhu,Qiyong Gong,Hu Zhang,Zhongwei Gu,Kui Luo

DOI: https://doi.org/10.1016/j.bioactmat.2022.09.016

IF: 18.9

2023-04-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.028.].

engineering, biomedical,materials science, biomaterials
Corrigendum: Crosstalk between cGAS-STING pathway and autophagy in cancer immunity

Qijun Lu,Yukun Chen,Jianwen Li,Feng Zhu,Zhan Zheng

DOI: https://doi.org/10.3389/fimmu.2023.1216456

IF: 7.3

2023-05-19

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1139595.].

immunology
Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Cunqing Kong,Xingcai Chen

DOI: https://doi.org/10.2147/ijn.s422584

IF: 7.033

2023-05-01

International Journal of Nanomedicine

Abstract:[This corrects the article DOI: 10.2147/IJN.S388996.].

pharmacology & pharmacy,nanoscience & nanotechnology
Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

Wenqian Zhang,Jiewen Fu,Jiaman Du,Xiaoyan Liu,Jingliang Cheng,Chunli Wei,Youhua Xu,Junjiang Fu

DOI: https://doi.org/10.3389/fimmu.2024.1518823

IF: 7.3

2024-11-17

Frontiers in Immunology

Abstract:This article is a correction to: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

immunology
Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing

Michel Demeule,Jean-Christophe Currie,Cyndia Charfi,Alain Zgheib,Isabelle Cousineau,Véronique Lullier,Richard Béliveau,Christian Marsolais,Borhane Annabi

DOI: https://doi.org/10.3389/fimmu.2024.1389603

IF: 7.3

2024-02-28

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2024.1355945.].

immunology

Correction to "Mannosylated STING Agonist Drugamers for Dendritic Cell-Mediated Cancer Immunotherapy"

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles"

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Author Correction: STEEP mediates STING ER exit and activation of signaling

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Author Correction: Anti-tumour Immunity Controlled Through Mrna M 6 A Methylation and YTHDF1 in Dendritic Cells

Correction: Synthesis and Immunological Evaluation of MUC1 Glycopeptide Conjugates Bearing N-acetyl Modified STn Derivatives As Anticancer Vaccines.

Author Correction to ‘mevalonate Improves Anti-Pd-1/pd-l1 Efficacy by Stabilizing CD274 Mrna’ [acta Pharmaceutica Sinica B 13 (2023) 2585–2600]

Correction To: Targeted Therapy for Cisplatin‐resistant Lung Cancer Via Aptamer‐guided Nano‐zinc Carriers Containing USP14 Sirna

Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Correction to “Targeting the Spike: Repurposing Mithramycin and Dihydroergotamine to Block SARS-CoV-2 Infection”

Corrigendum to “A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody” [Bioact. Mater. 21 299–312]

Corrigendum: Crosstalk between cGAS-STING pathway and autophagy in cancer immunity

Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review [Corrigendum]

Corrigendum: A disintegrin and metalloproteinase domain 10 expression inhibition by the small molecules adenosine, cordycepin and N6, N6-dimethyladenosine and immune regulation in malignant cancers

Corrigendum: Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing